Regeneron Pharmaceuticals Inc (REGN)

Net profit margin

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Net income (ttm)	US$ in thousands	4,578,000	4,458,600	4,499,300	4,412,600	4,654,500	4,321,700	3,857,800	3,953,600	3,991,100	4,299,000	4,182,700	4,338,400	5,370,300	5,686,800	7,933,600	8,075,300	6,995,500	6,205,400	4,003,800	3,513,200
Revenue (ttm)	US$ in thousands	14,247,800	14,214,200	14,085,700	14,202,000	13,847,100	13,489,100	13,100,100	13,117,200	13,097,300	12,670,800	12,369,900	12,172,900	13,710,200	14,226,800	16,508,100	16,071,700	13,542,900	12,384,100	9,197,600	8,497,100
Net profit margin		32.13%	31.37%	31.94%	31.07%	33.61%	32.04%	29.45%	30.14%	30.47%	33.93%	33.81%	35.64%	39.17%	39.97%	48.06%	50.25%	51.65%	50.11%	43.53%	41.35%